李慧芬 / 吳紹進

康哲藥業 (00867.HK)

2014-11-01

康哲藥業(00867.HK)有吸引的風險回報率

康哲藥業(00867.HK)的商業模式屬於可以複製,預料2015至2017年的盈利複合增長達29%,有吸引的風險回報率。由於看好其第三方醫藥推廣商的定位,可受惠於處方藥市場快速增長。

(The above displayed are just writers’ own opinions and for readers’ reference only. Financial markets are volatile and please be careful of the risks.)NOTICE

Investment involves risk. It is as likely that losses will be incurred rather than profits made as a result of buying and selling investment and financial products. Before investment, you should be aware of all the risks involved and carefully consider your investment objectives, trading experience, and level of risk acceptance. If you have any question, please seek advice from an independent professional advisor.

  • WeChat
  • QQ